Neosaxitoxin (NeoSTX) Alone and in Combination With Bupivacaine as Prolonged Duration Local Anesthetics: A Phase I Investigator-initiated Dose Escalation Study

Trial Profile

Neosaxitoxin (NeoSTX) Alone and in Combination With Bupivacaine as Prolonged Duration Local Anesthetics: A Phase I Investigator-initiated Dose Escalation Study

Completed
Phase of Trial: Phase I

Latest Information Update: 23 Feb 2016

At a glance

  • Drugs Neosaxitoxin (Primary) ; Bupivacaine
  • Indications Pain
  • Focus Adverse reactions
  • Most Recent Events

    • 16 Feb 2016 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov record.
    • 26 Aug 2015 Status changed from completed to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 15 Feb 2015 Treatment arms have been changed from 3 to 4 and planned number patients have been changed from 77 to 84 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top